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Abstract
In their IZA Discussion Paper 10247, Johansson and Lee claim that the main result
(Proposition 3) in Abbring and Van den Berg (2003b) does not hold. We show that
their claim is incorrect. At a certain point within their line of reasoning, they make
a rather basic error while transforming one random variable into another random
variable, and this leads them to draw incorrect conclusions. As a result, their paper
can be discarded.
∗We are grateful to Arne Uhlendorff, Johan Vikstro¨m, Tiemen Woutersen and Olof A˚slund for inter-
esting discussions.
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The Netherlands; and CEPR. E-mail: jaap@abbring.org. Web: jaap.abbring.org.
‡University of Bristol, IFAU-Uppsala, IZA, ZEW, University of Mannheim, and CEPR.
§The main text of this paper is identical to our IZA Discussion Paper 10248 from September 2016. We
have added an appendix in which we discuss related files currently (July 20, 2019) posted on M.J. Lee’s
web site. We note that these files simply reiterate Johansson and Lee’s earlier claims, which were shown
to be false both in our IZA Discussion Paper 10248 and, at least twice, in peer review at a major journal.
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1 Introduction
In a 2003 article in Econometrica (Abbring and Van den Berg, 2003b) we analyzed the
specification and identification of causal multivariate duration models. We focused on the
case in which one duration captures the point in time at which a treatment is initiated and
one is interested in the effect of this treatment on some outcome duration. We defined a “no
anticipation of treatment” assumption and showed that this assumption in a model frame-
work inspired by the mixed proportional hazards model delivers identification. The model
framework allows for dependent unobserved heterogeneity and does not require exclusion
restrictions on covariates. In a nutshell, the timing of events conveys useful information on
the treatment effect.
In their IZA Discussion Paper 10247, Johansson and Lee (henceforth JL) claim that our
main identification result (Proposition 3, for our Model 1A) does not hold.1 JL examine two
model versions, which they refer to as DGP1 and DGP2. It is good custom that comments
on articles from other researchers phrase their statements in terms of the notation and
model specification of the original article. However, JL do not make this effort. They claim
that their DGP1 captures our model (in particular, our Model 1A) and that our proof of
Proposition 3 does not apply to DGP1. From this, they conclude that our proof is incorrect
and Proposition 3 is not true.
In this note we show that JL’s claims are incorrect. They make a rather basic error
when deriving their DGP1 from our Model 1A. Consequently, DGP1 and our Model 1A
are not equivalent, and the fact that our proof of Proposition 3 does not apply to DGP1
has no bearing on its validity. We show that, in fact, their DGP2, for which they do not
raise similar concerns, is consistent with our model, in contrast to JL’s claims.
In Section 3 we develop the setup in terms of JL’s notation. We discuss properties of
our Model 1A and show that these immediately refute statements early on in JL about our
identification analysis. In Section 3 we explain the key error in JL’s derivations. Section 4
concludes and critically assesses awkward remarks in JL about the empirical researchers
who cited our 2003 Econometrica article.
1JL do not specifically refer to our Proposition 3. However, halfway their page 4, they do refer to the
“main identification finding of [Abbring and Van den Berg (2003b)] (pp. 1505–1506)”, and our Proposition
3 is the only relevant formal identification result on the pages 1505–1506 of the Econometrica article.
Moreover, on page 13 of JL, they refer to our Model 1A, and Proposition 3 is the main identification result
for Model 1A.
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2 Johansson and Lee’s setup and notation
The setup, in JL’s notation, is a model with a treatment duration W and an outcome
duration Y (throughout, following JL, we will keep observed covariates and unobserved
heterogeneity implicit as these are not relevant to the argument). The treatment duration
W has a hazard rate hW (w) and Lebesgue density
fW (w) = hW (w) exp
(
−
∫ w
0
hW (τ)dτ
)
(1)
at duration w. The outcome duration Y given W = w has a hazard rate h0(y) at times
y ≤ w and a hazard rate h1(y) at times y > w, with corresponding Lebesgue density
fY |W (y|w) =
{
h0(y) exp
(− ∫ y
0
h0(τ)dτ
)
if y ≤ w and
h1(y) exp
(− ∫ w
0
h0(τ)dτ −
∫ y
w
h1(τ)dτ
)
if y > w.
(2)
The joint density of (W,Y ) at (w, y) is fY |W (y|w)fW (w).
In our 2003 Econometrica article, we were specifically interested in the differences be-
tween the hazard rates h0 and h1, which capture the “treatment effects” of the event at
time W on the outcome duration Y . Therefore, we provided results on the identification
of h0 and h1 under general conditions. To this end, we used that our Model 1A embeds an
independent competing risks model with hazard rates hW and h0 for the so-called “iden-
tified minimum” of W and Y (i.e., their minimum and whether this minimum is equal to
W or equal to Y ). That is, we used that the subdensities of Y on {Y < W} and W on
{W < Y } (which, together, fully characterize the distribution of this identified minimum)
equal
− d
dy
Pr (Y > y, Y < W ) = h0(y) exp
(
−
∫ y
0
h0(τ)dτ −
∫ y
0
hW (τ)dτ
)
(3)
and
− d
dw
Pr (W > w,W < Y ) = hW (w) exp
(
−
∫ w
0
hW (τ)dτ −
∫ w
0
h0(τ)dτ
)
, (4)
respectively (see also JL’s (2.4)(i) and (2.4)(ii)). This intermediate result is key because it
allowed us to apply Abbring and Van den Berg’s (2003a) identification result for the com-
peting risks model to establish the identification of hW and h0 (as well as, in the general
setting with observed covariates and unobserved heterogeneity, the identification of the co-
variate effects on these hazard rates and the distribution of the unobserved heterogeneity
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in them) from data on the identified minimum of W and Y . Abbring and Van den Berg
(2003a) proved a one-to-one mapping between the competing risks model and the distri-
bution of the identified minimum. As is intuitively clear, and apparent from Equations (3)
and (4), the distribution of the identified minimum of W and Y only involves treatment
and outcome hazards before either the treatment or the outcome event occurs and does
not depend on the post-treatment outcome hazard (or, for that matter, the post-outcome
treatment hazard). Indeed, the specification of the hazard rates after the minimum of W
and Y is irrelevant for the competing risks identification result. The competing risks model
in Abbring and Van den Berg (2003a) and the competing risks part of our Model 1A are
equivalent.2 In particular, in Model 1A (without covariates and unobserved heterogeneity),
the implied submodel for the identified minimum of W and Y is an independent competing
risks model, despite the fact that W and Y will generally be dependent if h0 and h1 differ.
JL state halfway their page 4 that h0 = h1 (“no treatment effects”) is necessary for our
key intermediate result that Model 1A embeds an independent competing risks model with
hazard rates hW and h0. This is false. This should be clear from the previous paragraphs,
but we can illuminate it further by examining the subsurvival functions Pr(Y > y, Y < W )
of Y on {Y < W} and Pr(W > w,W < Y ) of W on {W < Y }, in order to verify that
Equations (3) and (4) hold for general h0 and h1, including cases where h0 6= h1. The
subsurvival function of Y on {Y < W} satisfies
Pr (Y > y, Y < W )
=
∫
Pr (Y > y, Y < W |W = w) fW (w)dw
=
∫ ∞
y
Pr (y < Y < w|W = w) fW (w)dw
=
∫ ∞
y
∫ w
y
fY |W (τ |w)dτfW (w)dw
=
∫ ∞
y
[
exp
(
−
∫ y
0
h0(τ)dτ
)
− exp
(
−
∫ w
0
h0(τ)dτ
)]
fW (w)dw.
(5)
Differentiating the left-hand and right-hand sides of (5) with respect to y, substituting (1),
integrating, and multiplying by −1 gives (3). An analogous derivation for the subsurvival
function of W on {W < Y } gives (4). Consequently, (3) and (4) hold generally, and this
2Underlying this equivalence is the no-anticipation assumption for potential outcomes made in Abbring
and Van den Berg (2003b), which ensures that the potential outcome hazards before treatment do not
depend on the eventual treatment time.
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confirms that, in contrast to what JL claim halfway their page 4, Abbring and Van den
Berg’s (2003a) results for the competing risks model can be applied to the model for the
identified minimum of W and Y embedded in Abbring and Van den Berg’s (2003b) model
of treatment effects.
3 Johansson and Lee’s error
It is easy to see where JL go wrong in their own derivations. Halfway their page 6, they
claim that we have adopted DGP1, which they associate with their Equation (2.2). For a
proof, they refer to their Appendix. In this Appendix, at the top of page 13, they specify the
hazard rate of the potential outcome Y ∗(w), evaluated at the elapsed duration y, as h0(y)
if y ≤ w and as h1(y) if y > w. This hazard rate specification indeed corresponds to our
Model 1A. The subsequent equation in their Appendix is supposed to capture Y ∗(w) as the
inverse of the corresponding integrated hazard evaluated in a standard exponential random
variable, as is clear from their reference to the equation halfway Abbring and Van den Berg
(2003b, p. 1496) and the corresponding discussion below their Equation (2.2). However, the
integrated hazard that is used here is not the correct integrated hazard, because it is not
the integral of the hazard in the equation at the top of page 13. Specifically, if w > Y ∗(w)
then the integrated hazard should equal
∫ Y ∗(w)
0
h0(τ)dτ . Instead, in this case, JL take it
to equal
∫ w
0
h0(τ)dτ −
∫ w
Y ∗(w) h1(τ)dτ .
3 Of course, this leads to a very peculiar DGP1 with
absurd implications. However, DGP1 is not consistent with our Model 1A and its absurd
implications are solely due to the mistake by JL and do not carry over to our Model 1A.
If JL would have used the correct integrated hazard instead, they would have ended up
with their DGP2 instead of DGP1. To see this, note that their Equation (2.6)(i) applies if
exp
[
−
∫ W
0
h0(τ)dτ −
∫ Y
W
h1(τ)dτ
]
≤ exp
[
−
∫ W
0
h0(τ)dτ
]
⇐⇒ Y ≥ W
and that their Equation (2.6)(ii) applies if
exp
[
−
∫ Y
0
h0(τ)dτ
]
> exp
[
−
∫ W
0
h0(τ)dτ
]
⇐⇒ Y < W,
3From JL’s calculations for the special case with constant hazards, in particular their derivation of
(3.6) in their Appendix, it is clear that that they indeed interpret
∫ Y ∗(w)
w
h1(τ)dτ as −
∫ w
Y ∗(w) h1(τ)dτ if
w > Y ∗(w).
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where we have used JL’s assumption that h0(τ) > 0 and h1(τ) > 0 for all τ (page 4).
Moreover, the left-hand side of Equation (2.6)(i) involves the correct integrated hazard of
Y evaluated at random W and Y such that Y ≥ W , ∫W
0
h0(τ)dτ +
∫ Y
W
h1(τ)dτ , and the
left-hand side of Equation (2.6)(ii) involves the correct integrated hazard of Y evaluated at
random W and Y such that Y ≤ W , ∫ Y
0
h0(τ)dτ (note that both are identical and correct
in the boundary case Y = W ). Consequently, in contrast to what JL claim, their DGP2
specified by Equation (2.6) is consistent with our Model 1A. Moreover, as JL note halfway
page 6, under DGP2, (3) and (4) hold for general h0 and h1. Taken together, this implies
that JL’s key claim that (3) and (4) cannot be used in the identification analysis of Model
1A is wrong.
Halfway page 6, JL raise a new concern about their DGP2, and thus our Model 1A:
Information on the post-treatment outcome hazard h1 can only be obtained from the
selected subpopulation with Y > W . We share this concern; in fact, this is one aspect of
the selection problem that is at the core of our paper and that we addressed successfully
in it.4 JL do not show that this concern invalidates our identification results, in particular
our Proposition 3. Rather, they propose to infer some treatment effect parameters by
regressing Y on W in a subsample of the population with Y > W and claim that the
resulting estimator is inconsistent. We never proposed this ad hoc procedure and we would
certainly not recommend it. In any case, its failure to produce a consistent estimator of
certain treatment effects does not prove our identification results wrong.
In sum, JL make a basic error in deriving their DGP1 from our Model 1A. This leads
them to incorrectly claim that their DGP1 and our Model 1A are equivalent. Instead,
our Model 1A corresponds their DGP2, to which their concerns about our identification
analysis do not apply. After reading JL, one may wonder why these misunderstandings
have not surfaced in an earlier stage of the publication process. Indeed, when presenting
their claim that we adopted DGP1 in Abbring and Van den Berg (2003b), JL note halfway
their page 14 that “[Abbring and Van den Berg] did not object to DGP1, nor did they
suggest DGP2”. Now, JL have not offered us the opportunity to respond to the most recent
version of their note before they submitted it for publication as an IZA Discussion Paper.
We did communicate with JL about previous drafts of their paper in 2014, both directly,
after they sent us their paper’s first draft in January 2014, and indirectly through the
4Other, more subtle aspects of this problem concern the selection on the unobservable heterogeneity
factors that is kept implicit in JL and here.
6
editorial process at a journal. In these communications, we pointed out a logical flaw in
an argument they used at the time, and that flaw has disappeared from the current draft
(they claimed that h0 = h1 is necessary for (3) and (4) to hold but only showed it to be
sufficient). We also directly demonstrated that their claim that h0 = h1 is necessary for (3)
and (4) to hold is incorrect, by providing, as in this Rebuttal, elementary calculations that
show that these equations hold generally. At the time, we did not provide an exhaustive
list of all aspects of their paper that we disagreed with, because this was not necessary
to make our point that they were wrong. In particular, we did not specifically refer to
JL’s DGP1 in our earlier private communication with them. The reader can rest assured,
though, that both of us disagree with many things that we never explicitly mentioned or
objected to.
4 Conclusion
The claims in JL’s paper about the results in Abbring and Van den Berg (2003b) can be
discarded.
In their paper, JL observe that our paper has been often cited by empirical studies, and
they mention a number of authors who cited our work. In the light of what JL perceive
as an incorrectness in our paper, they speculate about the reason for the high citation
score. Specifically, they claim that “the most likely reason is that Abbring and Van den
Berg (2003b) is a difficult paper to read and the applied studies in the literature simply
took the finding at the face value”. We view this as a preposterous statement. It offends
the empirical researchers who cite our work, by depicting them as simple minds unable
to understand methodological work. Our current note provides a better reason: our 2003
finding is correct.
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Appendix. Update on files currently on Lee’s web site
At sites.google.com/site/mjleeku/working-papers, M.J. Lee currently (July 20, 2019) posts
an old (March 11, 2015) version of the September 2016 IZA Discussion Paper 10247 that
this Rebuttal shows to be incorrect. The only difference between the two papers seems to
be that the last paragraph on page 10 in the March 2015 paper does not appear in the
September 2016 IZA Discussion Paper. Our Rebuttal does not refer to this paragraph, so
applies without change to the March 2015 paper on Lee’s website (except that the hazard
rate “at the top of page 13” is now halfway page 13, etcetera).
Lee’s web site also offers a more recent “Re-rebuttal” (December 2, 2016), in which JL
respond to our Rebuttal. The main argument in this Re-rebuttal, on its page 3, is essentially
the same as the argument in the first part of their paper’s Appendix. In Section 3, we have
already explained in detail why this argument is incorrect. To be sure, we reiterate our
main objection to JL’s argument here.
JL claim that our main identification result (Proposition 3, for our Model 1A) does not
hold (they are not explicit about this, but see our Footnote 1). JL seem to agree with us that
a homogeneous special case of our Model 1A (in JL’s notation) specifies the hazard rate
of the “treatment” duration W at time w as hw(w) and the hazard rate of the “outcome”
duration Y given treatment at time W as h0(y) at times y ≤ W (before treatment) and
as h1(y) at times y > W (after treatment). In our original identification analysis of Model
1A, we directly derived this specification’s implications for the joint distribution of (W,Y )
using that the integrated hazard of Y at y given W equals
∫ y
0
h0(τ)dτ if y ≤ W and∫W
0
h0(τ)dτ +
∫ y
W
h1(τ)dτ if y > W (which follows directly from the homogeneous special
case of our model). As we pointed out in Section 3, JL instead use
∫W
0
h0(τ)dτ−
∫W
y
h1(τ)dτ
for the integrated hazard of Y given W at y < W . This does not follow from our model,
makes no sense, and is the reason JL cannot reproduce our results.
Note that JL use a more indirect approach to study our model’s implications for the
distribution of (W,Y ) than we did. They specify the “DGP” corresponding to our Model
1A (we did not refer to a “DGP”) by constructing W and Y from independent uniform
random variables using the inverse probability transform (we used a similar construction
earlier in the paper to relate our analysis to the potential-outcomes framework in the
treatment-effects literature, but not in our analysis of Model 1A). Eventually, this should
however lead to the same conclusions. It doesn’t, because they use an incorrect distribution
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function, based on an incorrect integrated hazard, in their construction.
In sum, JL’s arguments continue to be fatally flawed. Indeed, like a 2014 version of
JL’s paper, the paper and Re-rebuttal currently on Lee’s web site were peer reviewed at a
major economics journal and rejected for being incorrect.
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